PI Industries shares surge 5% after biggest customer Kumiai Chemical raises guidance

Japan-based Kumiai Chemical Industries has raised its revenue guidance by 9% and EBITDA forecast by 34%.

Japan-based Kumiai Chemical Industries has raised its revenue guidance by 9% and EBITDA forecast by 34%.

Mid-sized private banks remain a key focus for BofA in the current environment. “They should also be a better beta play on the eventual macro recovery in India,” Anand Swaminathan, Senior Analyst – India at BofA Securities said.

The entire IPO proceeds will be received by the company. The IPO proceeds will be utilised for expanding production capacity of seamless and welded tubes and pipes, and working capital requirements.

Garden Reach will also use its experience of constructing complex maritime platforms like warships and survey and research vessels to build this PRV at its yard in Kolkata.

The ODC will comprise a dedicated team of skilled engineers. It will focus on enhancing Tennant’s product innovation, optimising performance, and integrating smart automation into its industrial cleaning portfolio.

Mazagon Dock shares had hit a record high of ₹3,775 on the day it reported its quarterly results on May 29. However, the stock dropped 10% in the next two trading sessions after the numbers were a miss on expectations.

At the interbank foreign exchange, the rupee opened on a weak note at 85.69 and slipped further by 25 paise to 85.86 against the American currency in early trade.

Within equities, financials remain a favourite for BofA and many investors. Meanwhile, newer themes like electronics manufacturing, semiconductors, biofuels, green hydrogen, and data centres are also drawing increasing interest.

Gland Pharma Share Price | In a stock exchange filing, the company said it has received approval from the US drug regulator for Angiotensin II Acetate injection, 2.5 mg/mL, for treating blood pressure in adults with septic or other distributive…

Indegene Share Price | On Tuesday, June 3, CNBC-TV18 reported, citing sources that CA Dawn Investments, an affiliate of US-based Carlyle, was likely to sell a 10.2% stake in the healthcare tech firm via block deals valued at approximately ₹1,420…